51 /100
HIGH RISK
Score updated Jul 14, 2026

HIT — Health In Tech, Inc. Dilution Risk Tracker

Track HIT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HIT — Get alerts when the score changes →

As of July 14, 2026, Health In Tech, Inc. (HIT) has a DilutionWatch DilutionScore of 51/100, rated HIGH dilution risk. Health In Tech, Inc. has a market capitalization of $65.02M, 57.35M shares outstanding, 15 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
62
💰 Cash Runway
0
📊 Float Risk
60
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
15%
🔄 Reverse Split 30%
• 50-day avg $1.41 approaching $1 threshold
🔔 Track HIT — Get forecast alerts →

💹 Market Data

Market Cap$65.02M
Shares Outstanding57.35M
Float20.07M
Cash$10.33M
Debt$121.6K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 46.8% shares (2026Q1 vs prior)
15 institutional holders · 3.11M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 1.13M shares
#2 Mink Brook Asset Management LLC 806.5K shares
#3 HEIGHTS CAPITAL MANAGEMENT, INC 373.3K shares
+ 12 more holders Sign up free to view →

📉 Short Interest

Short Interest565.4K
Days to Cover4.6
% of Float2.8%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for HIT Shareholders

Health In Tech, Inc. (HIT) has a DilutionScore of 51/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

DilutionWatch's EDGAR monitoring for HIT shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for HIT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for HIT alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track HIT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HIT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for HIT
📊 HIT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 HIT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.